<?xml version="1.0" encoding="UTF-8"?>
<ref id="B135-pharmaceutics-12-00171">
 <label>135.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Li</surname>
    <given-names>Y.</given-names>
   </name>
   <name>
    <surname>Lin</surname>
    <given-names>Z.</given-names>
   </name>
   <name>
    <surname>Guo</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Zhao</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Xia</surname>
    <given-names>Y.</given-names>
   </name>
   <name>
    <surname>Wang</surname>
    <given-names>C.</given-names>
   </name>
   <name>
    <surname>Xu</surname>
    <given-names>T.</given-names>
   </name>
   <name>
    <surname>Zhu</surname>
    <given-names>B.</given-names>
   </name>
  </person-group>
  <article-title>Inhibition of H1N1 influenza virus-induced apoptosis by functionalized selenium nanoparticles with amantadine through ROS-mediated AKT signaling pathways</article-title>
  <source>IJN</source>
  <year>2018</year>
  <volume>13</volume>
  <fpage>2005</fpage>
  <lpage>2016</lpage>
  <pub-id pub-id-type="doi">10.2147/IJN.S155994</pub-id>
  <pub-id pub-id-type="pmid">29662313</pub-id>
 </element-citation>
</ref>
